At the current share price, an investment in watch maker Movado
Second-quarter sales and earnings came in ahead of analyst expectations, and the stock is up 4% on another down day for the market. Management attributed the results to "the continued customer appeal of our diverse portfolio of brands," which spans mass-market brands such as Estee Lauder's
If you noticed the outside names, Movado also licenses brands in what it considers its wholesale business and recently introduced a new Lacoste line of watches. Archrival Fossil
Customers welcomed the product mix, and the company sold merchandise at a higher margin. As a result, the gross margin increased, excluding liquidations. Additionally, operating profits improved and net income grew 4.7% from the same quarter last year.
The company is continuing to develop in China, and the international business overall grew 24%, excluding discontinued product sales. Overseas strength is nothing new, and many companies are benefiting from expanding around the globe. Current shareholders definitely aren't complaining, and management is sticking to its earnings goals for the full year, implying Movado is set for another year of bottom-line gains.
For related Foolishness:
Fool contributor Ryan Fuhrmann has no financial interest in any company mentioned. Feel free to email him with feedback or to discuss any companies mentioned further. The Fool has an ironclad disclosure policy.
More from The Motley Fool
Why Hewlett Packard Enterprise, Qudian, and Movado Group Slumped Today
Find out which of these companies is losing a key executive.
Movado Group, Inc. Boosts Full-Year Outlook
CEO Efraim Grinberg says the watchmaker is "well positioned" for the all-important holiday shopping season.
What Happened in the Stock Market Today
On a record day for the major benchmarks, shares of Movado Group soared on earnings and GW Pharmaceuticals rose following positive trial results.